- Home
- CODA vs PYXS Comparison
CODA vs PYXS Comparison
Compare CODA & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODA
- PYXS
- Stock Information
- Founded
- CODA 1994
- PYXS 2018
- Country
- CODA United States
- PYXS United States
- Employees
- CODA N/A
- PYXS N/A
- Industry
- CODA Industrial Machinery/Components
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- CODA Industrials
- PYXS Health Care
- Exchange
- CODA Nasdaq
- PYXS Nasdaq
- Market Cap
- CODA 89.7M
- PYXS 101.1M
- IPO Year
- CODA N/A
- PYXS 2021
- Fundamental
- Price
- CODA $8.14
- PYXS $1.50
- Analyst Decision
- CODA Strong Buy
- PYXS Strong Buy
- Analyst Count
- CODA 1
- PYXS 8
- Target Price
- CODA $11.00
- PYXS $9.43
- AVG Volume (30 Days)
- CODA 30.2K
- PYXS 817.5K
- Earning Date
- CODA 01-29-2025
- PYXS 11-12-2024
- Dividend Yield
- CODA N/A
- PYXS N/A
- EPS Growth
- CODA N/A
- PYXS N/A
- EPS
- CODA 0.26
- PYXS N/A
- Revenue
- CODA $18,824,676.00
- PYXS $16,146,000.00
- Revenue This Year
- CODA $8.20
- PYXS N/A
- Revenue Next Year
- CODA $18.67
- PYXS N/A
- P/E Ratio
- CODA $31.23
- PYXS N/A
- Revenue Growth
- CODA N/A
- PYXS N/A
- 52 Week Low
- CODA $5.21
- PYXS $1.39
- 52 Week High
- CODA $9.89
- PYXS $6.85
- Technical
- Relative Strength Index (RSI)
- CODA 44.17
- PYXS 36.16
- Support Level
- CODA $8.25
- PYXS $1.39
- Resistance Level
- CODA $9.00
- PYXS $1.82
- Average True Range (ATR)
- CODA 0.43
- PYXS 0.10
- MACD
- CODA 0.04
- PYXS 0.03
- Stochastic Oscillator
- CODA 30.62
- PYXS 25.58
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. It operates in two segments: Marine Technology Business and Marine Engineering Business. The Technology Business develops proprietary solutions for both the commercial and defense subsea market. Its solutions include hardware and software for Geophysical Systems, Motion & Positioning Systems, and Real-Time Volumetric Imaging Sonar. The Engineering Business segment provides engineering services to a range of clients in the defense markets. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Marine Technology Business segment.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.